Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy

Saved in:
Bibliographic Details
Published in:Thrombosis research 2021-07, Vol.203, p.1-4
Main Authors: Rhoades, Ruben, Leong, Ron, Kopenitz, Jason, Thoma, Brandi, McDermott, Lydia, Dovidio, Joseph, Barletti, Shannon, Gong, Jerald Z., Massey, Howard T., McKenzie, Steven E., Rame, J. Eduardo, Al-Rawas, Nawar
Format: Article
Language:English
Subjects:
Activated partial thromboplastin time (aPTT)
Acute respiratory distress syndrome (ARDS)
Anti-Xa
Coagulopathy
COVID-19
Extracorporeal membrane oxygenation (ECMO)
Heparin
Letter to the Editors-in-Chief
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0049-3848
1879-2472
DOI:10.1016/j.thromres.2021.04.008